Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2023 ▲▼ | Q4 2023 ▲▼ | Change ▲▼ | Q3 2023 ▲▼ | Q4 2023 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Hims & Hers Health, Inc.CL A(HIMS) | 3,733,381 | 3,833,381 | +100,000 | $23.48M | $34.12M | 46.49% | +$10.63M |
| Theseus Pharmaceuticals, Inc. | 4,108,796 | 4,108,796 | 0 | $11.05M | $16.64M | 22.67% | +$5.59M |
| Disc Medicine, Inc.(IRON) | 243,513 | 243,513 | 0 | $11.44M | $14.07M | 19.16% | +$2.63M |
| Kinnate Biopharma Inc. | 3,525,957 | 3,525,957 | 0 | $4.94M | $8.36M | 11.39% | +$3.42M |
| 23andMe Holding Co.CL A | 0 | 232,200 | +232,200 | $0 | $212.1K | 0.29% | +$212.1K |
| Aclaris Therapeutics, Inc.COM(ACRS) | 1,258,243 | 0 | -1,258,243 | $8.62M | $0 | — | -$8.62M |
| Compass Therapeutics, Inc.COM(CMPX) | 1,246,977 | 0 | -1,246,977 | $2.46M | $0 | — | -$2.46M |
| Pharvaris N.V.COM COM | 33,142 | 0 | -33,142 | $691.7K | $0 | — | -$691.7K |